7,718.60

-29.11

-0.38%

53,414.25

-271.85

-0.51%

26,506.99

-77.11

-0.29%

2,975.65

+7.38

+0.25%

14.53

+0.21

+1.47%

4,476.60

-63.30

-1.39%

79,923.02

+212.30

+0.27%

Crude Oil Oct 26

91.48

+0.18

+0.20%

NasdaqCM - Nasdaq Real Time Price USD

bioAffinity Technologies, Inc. (BIAF)

Get top stock picks

15.27 +2.49 (+19.48%)

At close: September 4 at 4:00:01 PM EDT

10.36 -4.91 (-32.15%)

After hours: September 4 at 7:59:59 PM EDT

Get top stock picks

Loading Chart for BIAF

Chart Range Bar

Interval:

In partnership with ChartIQ

bioAffinity’s AI Lung-Cancer Stock Jumped Nearly 48% After a Reverse Split. What Would Have to Go Right?

bioAffinity’s AI Lung-Cancer Stock Jumped Nearly 48% After a Reverse Split. What Would Have to Go Right?

bioAffinity Technologies to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

bioAffinity Technologies to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

bioAffinity Technologies Shares Rise After CyPath Lung Surveillance Update

bioAffinity Technologies Shares Rise After CyPath Lung Surveillance Update

bioAffinity Technologies Advances CyPath Lung for Post-Treatment Lung Cancer Surveillance

bioAffinity Technologies Advances CyPath Lung for Post-Treatment Lung Cancer Surveillance

bioAffinity Technologies Advances CyPath® Lung for Surveillance of Lung Cancer Survivors

bioAffinity Technologies Advances CyPath® Lung for Surveillance of Lung Cancer Survivors

bioAffinity Technologies Signs Nationwide Federal Healthcare Distribution Agreement for CyPath Lung

bioAffinity Technologies Signs Nationwide Federal Healthcare Distribution Agreement for CyPath Lung

bioAffinity Technologies and AvMEDICAL Announce Nationwide Federal Healthcare Distribution Agreement for CyPath® Lung

bioAffinity Technologies and AvMEDICAL Announce Nationwide Federal Healthcare Distribution Agreement for CyPath® Lung

WallachBeth Capital Announces Closing of bioAffinity Technologies $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules

WallachBeth Capital Announces Closing of bioAffinity Technologies $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules

WallachBeth Capital Announces bioAffinity Technologies Pricing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules

WallachBeth Capital Announces bioAffinity Technologies Pricing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules

bioAffinity Technologies Announces Pricing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules

bioAffinity Technologies Announces Pricing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules

bioAffinity Technologies Publishes New Clinical Framework Addressing Growing Market for Pulmonary Nodule Risk Stratification and Early Lung Cancer Detection Using CyPath® Lung

bioAffinity Technologies Publishes New Clinical Framework Addressing Growing Market for Pulmonary Nodule Risk Stratification and Early Lung Cancer Detection Using CyPath® Lung

ISPC

PRPH

MBAI

MYGN

NDRA

XWEL

ICBU

BDSX

MYNZ

IZO.CN

Mobilize your Website

View Site in Mobile | Classic

Share by: